Market Overview

Benzinga's Top Downgrades

Share:
Related FINL
Why Finish Line Has 'More Legs To Run'
Morning Market Gainers
Finish Line guides EPS light (Investor's Business Daily)
Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

Sterne Agee downgraded Finish Line Inc (NASDAQ: FINL) from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%.

Analysts at UBS downgraded Elan Corporation plc (NYSE: ELN) from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57.

RW Baird downgraded Amylin Pharmaceuticals Inc (NASDAQ: AMLN) from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%.

William Blair downgraded Booz Allen Hamilton Inc (NYSE: BAH) from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.

Latest Ratings for FINL

DateFirmActionFromTo
Mar 2015B RileyDowngradesBuyNeutral
Mar 2015JefferiesMaintainsBuy
Mar 2015SusquehannaMaintainsPositive

View More Analyst Ratings for FINL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AMLN + BAH)

Around the Web, We're Loving...